VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were down 6.1% on Wednesday . The stock traded as low as C$0.16 and last traded at C$0.16. Approximately 16,500 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 263,513 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 6.1 %
The stock has a market cap of C$25.14 million, a P/E ratio of -4.79 and a beta of 0.39. The company’s fifty day moving average price is C$0.13 and its 200-day moving average price is C$0.13. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to start investing in penny stocks
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
